R&D Systems™ Recombinant Equine TGF-beta 1 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Equine TGF-beta 1 Protein is derived from CHO. The Recombinant Equine TGF-beta 1 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: NP_001075318
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 7040
• Molecular Weight (g/mol): Observed M.W.: 11-13kDa, reducing conditions, Theoretical M.W.: 13kDa
• Quantity: 10 μg
• Source: Chinese Hamster Ovary cell line,CHO-derived equine TGF-beta 1 protein Ala279-Ser390
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
• Common Name: TGF-beta 1
• Gene Symbol: TGFB1
• Biological Activity: Measured by its ability to inhibit the IL-4-dependent proliferation of HT-2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is typically 0.04-0.2ng/mL.
• Conjugate: Unconjugated
• Species: Equine
• Recombinant: Recombinant
• Expression System: Chinese Hamster Ovary cell line, CHO-derived Ala279-Ser390
• Purity or Quality Grade: >95%, by SDS-PAGE with Silver Staining